Neurostimulation Device Company Spark Biomedical Receives $217K NIH Grant to Help Infants Born with Opioid Addiction

By
Cathy Russey
-
Spark biomedical opioid wearable
Image: Wikimedia Commons (USAF Photographic Archives)
Spark Biomedical, a neurostimulation device company based in Dallas, received an SBIR grant totaling $217,690 from the National Institutes of Health HEAL initiative. Spark develop wearables to treat opioid withdrawal symptoms. The company said the money will be used to validate the use of transcutaneous auricular neurostimulation to relieve withdrawal symptoms in infants born with […]
To access this post, you must purchase Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).

RELATED ARTICLESMORE FROM AUTHOR